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Abstract
Background: To evaluate the quality of life (QOL) in relation to age, sex, clinical stage, postoperative complication,
and adjuvant chemotherapy in patients who underwent curative total gastrectomy with D2 lymphadenectomy and
Omega type esophagojejunostomy for gastric adenocarcinoma.
Methods: 69 patients were included. Lithuanian version of the European Organization for Research and Treatment
of Cancer Quality of Life Questionnaire Cancer 30 was sent to all of them from six months to two years after gastric
surgery for self-completion. 34 questionnaires were filled and were used as material for further analysis. Influence of
age (≥ 65 vs< 65), sex, clinical stage (I–II vs III), surgical complication, and adjuvant chemotherapy was assessed on
QOL in this retrospective cross-sectional case series study.
Results: The global health status was better in the group of patients aged over 65 (63.0 points vs 46.4, P = 0.0509).
The functional scales were higher in the same group of patients. Significant difference was only observed on the
social scale in favour of elders (P = 0.0039). Sex, clinical stage, surgical complications, and postoperative
chemotherapy had no significant influence on any aspect of QOL.
Conclusion: The global QOL and the social functioning was better in patients aged 65 years and over, compared
to patients under the age of 65 in the period of 6 to 18 months after a total gastrectomy with D2
lymphadenectomy and Omega esophagojejunostomy.
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Background
Improving cancer therapy leads to increasing survival
rates. In addition to this, there is more attention being
placed on the quality of life (QOL) which is mostly
dependent on cancer diagnosis and complex treatment
[1]. Thorough assessment on the QOL of patients is es-
pecially important when surgery is applied as a main op-
tion of treatment, as the operated patients often suffer
from various functional and psychological symptoms for
a considerably longer time than the average amount of
months following the surgery. These symptoms and
other aspects of health which necessitate for changes of
lifestyle, have to be analysed by investigating the QOL.
QOL is a multidimensional construct which represents
comfort and well-being of the patients, secondary to the
disease and treatment [2]. Research has shown that
patients want information not only about the treatment
outcomes but also about the influence of treatment on
their lifestyle [3]. This is the reason why the information
about the QOL should become a part of fully informed
consent taking procedure before surgical treatment [4].
On the other hand, when physicians consider QOL as
one of the points of prognosis after particular surgical
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procedure, they often rely solely on their personal pro-
fessional experience because there is not much formal
data about QOL except for few locations of cancer, for
instance, breast or prostate [5]. The rationale for this re-
search was the fact that little attention, if any, has been
focused on QOL after extended curative surgery for gas-
tric cancer with particular type of gastrointestinal con-
tinuity reconstruction. The aim of this retrospective
cross-sectional study was, therefore, to evaluate the
QOL in relation to age, sex, clinical stage, postoperative
complication, and adjuvant chemotherapy in patients
who underwent curative total gastrectomy with D2 lym-
phadenectomy and Omega type esophagojejunostomy
for gastric adenocarcinoma without distant metastases.
Methods
The curative R0 total gastrectomy for middle or/and
proximal gastric adenocarcinoma with reconstruction of
digestive tract by means of an esophagojejunostomy with
a jejunal loop and Braun’s side-to-side enteroanastomo-
sis was performed on 87 patients in the Institute of On-
cology of the Vilnius University, Lithuania, from January
2008 to July 2009. All specimens were evaluated histolo-
gically. Gastric adenocarcinoma was staged according to
7th edition of TNM classification of malignant tumours
[6]. An extended lymphadenectomy D2 was based on
principles described and developed by Japanese gastric
cancer association [7]. 69 patients, who were without
distant metastasis or proven recurrence 6 to 18 months
after surgery, were included into the retrospective cross-
sectional study. None of these patients received neoadju-
vant treatment prior to surgery.
The Lithuanian version of the European Organisation
for Research and Treatment of Cancer Quality of Life
Questionnaire Cancer 30 (EORTC QLQ-C30) was used to
assess the QOL of gastric cancer patients and sent to them
for self-completion in January 2010. 36 patients (52.2%)
had responded. 34 questionnaires were filled thoroughly
and they were used as material for further investigation.
The main characteristics of those patients are shown in
the Table 1. The influence of age (≥ 65 years vs. < 65), sex,
clinical stage (I–II vs III), surgical complication (yes vs.
no), and adjuvant chemotherapy (yes vs. no) was assessed
on QOL. All data are expressed as mean±using standard
deviation. Quality of life scores were compared between
groups using the Mann–Whitney U-test. Differences with
a P value of 0.05 were considered to be statistically signifi-
cant. Microsoft Office XP Excel 2007 Worksheets were
used for accumulation and analysis of data.
Results
The age of patients had an obvious tendency to influ-
ence the global health status (Figure 1A). It was better in
the group of patients aged 65 years and over (63.0 points
vs 46.4 points, P = 0.0509). The functional scales were
also higher in the group of patients aged 65 and over.
The significant difference was only observed on the so-
cial scale and the global outcome showed in favour of
elders (82.4 vs. 53.2, P = 0.0039). Symptoms, especially
pain (44.8 vs. 25.0) and insomnia (47.9 vs 29.6), were
more common in patients under age 65. However, the
differences between these groups were not significant
(Figure 1B).
Analysis of the influence of sex on the global health
status (54.2 vs. 56.5) and functional scales have shown
no differences between male and female (Figure 2A). Al-
though symptoms like nausea and vomiting, insomnia,
constipation were more often complained by woman
(24.5 vs. 8.8, 45.1 vs 31.4, 27.5 vs. 9.8, respectively), a
statistical significant difference was not found
(Figure 2B).
The global health status (63.7 vs. 44.6) and functional
scales were higher in patients with I and II clinical stages
for gastric adenocarcinoma (Figure 3A). On the other
hand, these patients expressed more symptoms such as
fatigue, nausea and vomiting, pain, dyspnoea, loss of
Table 1 Characteristics of 34 patients who filled the
EORTC QLQ-C30
Characteristics Value/patients Per cent
Age Median 64 –
Range 42-84 –
SD 10.91 –
≥ 65 18 52.9
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appetite, and diarrhoea (Figure 3B). Nevertheless, differ-
ences between groups were not statistical significant.
Neither statistical significant differences between
groups nor obvious trends, an analysis of surgical compli-
cations and adjuvant chemotherapy on QOL were
revealed.
Discussion
The studies on the QOL of gastric cancer patients
mostly feature the direct interview and evaluation of
patients’ symptoms or performance status by physician
[5], although the evaluation of QOL is more valuable
when it is expressed by the patients themselves [8]. Also,
any study on QOL should cover as many aspects of life
as possible. Kaptein et al. wrote a review on all QOL
studies of patients with gastric cancer which showed that
all the studies included physiological aspects but none of
them included social functioning [5]. As the biopsycho-
social model of medicine is increasingly becoming sig-
nificantly important, the wider spectrum QOL research
is becoming increasingly valuable [5,9].
The EORTC QLQ-C30 is an extensively tested ques-
tionnaire on cancer patients which can be used to
evaluate the QOL of cancer patients in any country.
Furthermore, it is a combination of adequate psycho-
metric characteristics which give an opportunity of
comparing between patients with different categories of
cancer [10]. The same questionnaire was used in the
studies which analysed QOL of cancer patients who
followed radical surgical procedures as well [10-13].
The EORTC QLQ-C30 consists of 30 items which ask
how the patient would rate his or her health and all
the aspects associated with it during the last week [14].
Every item belongs to a different scale or it is a single-
item measure. There are five functional scales, three
symptom scales, a global health status, and six single-
items in the questionnaire. All of the scales and single-
item measures have been transformed linearly, ranging
from 0 to 100. The data was evaluated by the guide-
lines of the EORTC [10,11]. It is important to note that
higher scores for the functional scales and the global
health status reflect better quality of life, while high
scores for the symptom scales represent problems
which influence the QOL negatively.
Total curative gastrectomy consists of two phases: the
removal of the stomach with a limited or extended lym-
phadenectomy and the reconstruction of the gastrointes-
tinal tract. Nowadays, the most popular method of
A. The functional scales and global health status 
B. Symptoms‘ scales
Figure 1 Impact of age on the quality of life at time of total gastrectomy with extended lymphadenectomy and Omega type
esophagojejunostomy (* P = 0.0039, ** P = 0.0509, Mann–Whitney U test).
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restoration of continuity of the gastrointestinal tract is
Roux-en-Y one [8]. This might be the reason why so lit-
tle information on outcomes of other reconstructions as
well as Omega technique can be found. The importance
of knowledge on postoperative QOL as it may be an im-
portant factor in clinical decision-making, including
considering surgery or not in a subgroup of patients
with limited life expectancy was emphasized [15].
Several studies analysed a relation between QOL and
clinical, demographic, and social parameters as it was
done in this study [14,16-20]. Analysis of global health
care status of our patients has shown, surprisingly, that
the elder patients scored a better QOL in comparison to
those younger, and is especially noticeable in social func-
tioning. It is not simple to explain this finding of the
study as other similar studies which pointed out a differ-
ent trend – younger patients had better QOL after gas-
tric surgery than older [19,20]. In our view, the fact that
the global QOL and the social functioning was better in
Lithuanian patients aged 65 years and over may be
related with a less demanding, and, therefore, slightly
more positive outlook to disease burden and surrounding
environment. Nevertheless, one should be cautious in
interpreting key finding of this study because of nature of
this study. On the other hand, de Liaño et al. also indi-
cated that older patients’ global health status was better,
however, he also found that older patients had more clin-
ical symptoms which is a contrasts to our study [14].
Physicians often link the advanced stage of cancer with
the poorer quality of life. Although the scales of the
earlier-stage cases were a little bit higher, this study as
well as Huang et al. study [18] had not shown any signifi-
cant differences between early and advanced cancer
stages when at least 6 month had passed after surgical
treatment. On the other hand, Matsushita et al. found
that patients in the later stage of gastric cancer had a sig-
nificantly worse quality of life [17]. Furthermore, there is
no single opinion about the influence of postoperative
complications following total gastrectomy on QOL. In
addition to our study, de Liano et al. stated that QOL
had no relation with postoperative complications. How-
ever, Matsushita et al. concluded that it negatively influ-
ences the physical functioning of gastrectomized patients
after 6 months [14,17]. We have to note that women had
higher scores almost in all functional and symptom’s
scales dimensions. Nevertheless, there were no statisti-
cally significant differences. Again, data are controversial
regarding gender role on QOL [14,19,21].
A. The functional scales and global health status
B. Symptoms‘ scales
Figure 2 Influence of sex on the quality of life at time of total gastrectomy with extended lymphadenectomy and Omega type
esophagojejunostomy (no significant differences).
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They are few limitations of this study. It is a retro-
spective study whereby there were a small number of
patients responders involved; it undoubtedly caused a
bias view. There was no control group. In addition to
this, as the QOL is a subjective feature, it is influenced
by not only diagnosis or treatment, but by the character
and psychological state of the patients as well [17].
Conclusions
Data of the study show that the global QOL and the so-
cial functioning was better in patients aged 65 years and
over, compared to patients under age 65 in the period of
6 to 18 months after a total gastrectomy with extended
lymphadenectomy and Omega esophagojejunostomy for
gastric adenocarcinoma without distant metastases and
recurrence. In our view, this study delineated a question
for further research related to type of curative surgery
for elderly and survivorship. It, as a retrospective cross-
sectional study of QOL after total gastrectomy with
Omega reconstruction of gastrointestinal tract, can pro-
vide background for design of both retrospective case–
control and prospective randomised clinical studies.
Meanwhile, results of previous and current studies that
include QOL in patients with gastric cancer should be
applied in preoperative as well as postoperative clinical
care, which aims at improving the QOL of these patients
after the total gastrectomy with particular method of
gastrointestinal reconstruction.
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